Department of Chemical Technology, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad 431 004 (MS), India.
Bioorg Med Chem Lett. 2010 Jan 15;20(2):742-5. doi: 10.1016/j.bmcl.2009.11.048. Epub 2009 Nov 15.
An improved protocol for the synthesis of a novel series of 1,2,4-triazines possessing 1,2,3-triazole and piperidine ring using 1-(1-substituted piperidin-4-yl)-1H-1,2,3-triazole-4-carbohydrazide, benzil, ammonium acetate and ZrOCl(2).8H(2)O as a catalyst in ethanol-water has been presented. The yields obtained are in the range of 87-94%. All the synthesized compounds (4a-4l) are novel and were evaluated for their in vitro antifungal activity. SAR for the series has been developed by comparing their MIC values with miconazole and fluconazole. Based on activity data SAR for the series has been developed. Compound 4c from the series was equipotent to miconazole against Candida albicans (MIC-25), Aspergillus niger (MIC-12.5) and Cryptococcus neoformans (MIC-25). Compound 4d was equipotent with miconazole against all tested organisms except Cryptococcus neoformans. Also compound 4i was equipotent with miconazole against C. albicans, A. niger and Fusarium oxysporum.
使用 1-(1-取代哌啶-4-基)-1H-1,2,3-三唑-4-甲酰肼、苯甲酰、乙酸铵和 ZrOCl(2).8H(2)O 作为催化剂,在乙醇-水中合成了一系列新型 1,2,4-三嗪,其具有 1,2,3-三唑和哌啶环。收率在 87-94%之间。所有合成的化合物(4a-4l)均为新型化合物,并对其进行了体外抗真菌活性评价。通过比较它们的 MIC 值与咪康唑和氟康唑,对该系列化合物进行了构效关系研究。根据活性数据,对该系列化合物进行了构效关系研究。该系列中的化合物 4c 对白色念珠菌(MIC-25)、黑曲霉(MIC-12.5)和新型隐球菌(MIC-25)的活性与咪康唑相当。化合物 4d 对所有测试的生物体(除新型隐球菌外)的活性与咪康唑相当。化合物 4i 对白色念珠菌、黑曲霉和尖孢镰刀菌的活性与咪康唑相当。